Sickle-cell disease: Two new therapeutic strategies.
D000755:Anemia, Sickle Cell / Q000188:drug therapy*; D000986:Antisickling Agents / Q000627:therapeutic use*; D004341:Drug Evaluation; D004910:Erythrocyte Membrane / Q000187:drug effects; D006801:Humans; D008968:Molecular Conformation; D010889:Piracetam / Q000627:therapeutic use*; D011736:Pyridoxine / Q000627:therapeutic use*; D011760:Pyrrolidinones / Q000627:therapeutic use*
D000986:Antisickling Agents; D011760:Pyrrolidinones; D011736:Pyridoxine; D010889:Piracetam